Advertisement
ALC vs MDT
Which Stock Would AI Choose? Alcon Inc. (ALC) vs. Medtronic plc (MDT) Stock Comparison
Key Takeaways
- Alcon Inc. (ALC) reported first-quarter 2026 net sales of $2.69 billion, up 10% year over year, driven by new product launches in surgical and vision care segments.
- Medtronic plc (MDT) shares experienced notable volatility in recent weeks, trading near 52-week lows amid broader market pressures and slower growth expectations relative to peers.
- ALC authorized a $1.5 billion share repurchase program over three years following its Q1 results, signaling confidence in cash generation and capital allocation.
- MDT maintains a significantly larger market capitalization and dividend yield compared to ALC, offering greater scale but facing scrutiny over organic revenue growth.
- Both companies operate in the medical technology sector with exposure to elective procedures and chronic disease management, though ALC focuses primarily on eye care while MDT spans multiple therapeutic areas.
- Recent market activity shows ALC demonstrating more consistent positive catalysts from product innovation, whereas MDT contends with analyst commentary on narrowing growth gaps versus larger medtech rivals.
Introduction
Alcon Inc. (ALC) and Medtronic plc (MDT) represent two prominent players in the healthcare technology space, each with distinct business models and market exposures. This comparison examines their recent performance, operational developments, and relative positioning to assist traders and investors evaluating opportunities within the medical devices and eye care industries. Market participants focused on sector rotation, growth versus stability trade-offs, or AI-driven signal analysis may find the analysis relevant when assessing portfolio allocations or short-term trading strategies in the current environment.
ALC Overview and Recent Performance
Alcon Inc. (ALC) develops, manufactures, and markets surgical equipment, devices, pharmaceuticals, and consumer vision care products primarily for eye diseases and disorders. In recent market activity, the stock has reflected positive sentiment tied to first-quarter 2026 results, with net sales rising 10% year over year to $2.69 billion, supported by 10 new product launches including advanced intraocular lenses and other innovations. Core diluted earnings per share increased 16% to $0.85, while the company maintained its full-year guidance and authorized a $1.5 billion share repurchase program. These factors contributed to steady price behavior amid broader healthcare sector movements, with emphasis on operational efficiency and product-driven growth.
MDT Overview and Recent Performance
Medtronic plc (MDT) is a global medical technology company offering device-based therapies across cardiology, diabetes, neuroscience, and other areas. Recent market activity has featured price volatility, with shares reaching new 52-week lows in May 2026 and trading below key moving averages. The company has navigated slower organic growth relative to some peers, alongside analyst notes highlighting a potential discount to large-cap medtech valuations. Developments such as ongoing operational streamlining and dividend maintenance have provided some support, though broader sentiment has reflected caution around revenue expansion pacing in the current period.
Trending AI Robots
Tickeron’s Trending AI Robots page showcases a curated selection of high-performing AI trading bots drawn from hundreds available on the platform. These bots trade thousands of different tickers using varied strategies, timeframes, and performance metrics tailored to prevailing market conditions. Only the strongest candidates, evaluated on backtested results, risk-adjusted returns, and adaptability, earn placement in the trending section. Available bots display a wide range of statistics, including win rates often spanning 55-75%, average trade durations from minutes to weeks, and diverse ticker sets focused on sectors like healthcare or broader indices. All AI trading bots feature distinct trading styles, strategies, timeframes, performances, statistics, and sets of tickers they trade. Review the full selection on the Trending AI Robots page for details suited to individual objectives.
Head-to-Head Comparison
Alcon Inc. (ALC) operates a focused business model centered on vision care and surgical ophthalmology, generating growth through targeted product innovation and elective procedure volumes. Medtronic plc (MDT) employs a diversified portfolio spanning multiple chronic disease categories, providing broader revenue stability but exposing it to varied regulatory and reimbursement dynamics. In recent momentum, ALC has benefited from visible catalysts such as new product introductions and capital return initiatives, while MDT has faced headwinds from relative growth perceptions and price consolidation. Risk factors for ALC include concentration in eye care markets and currency fluctuations, whereas MDT contends with integration of acquisitions and competition across device categories. Sector exposure places both in healthcare technology, though ALC offers narrower cyclical sensitivity compared to MDT’s multi-specialty footprint. Market sentiment has tilted toward ALC’s execution visibility, contrasting with ongoing evaluation of MDT’s margin and growth recovery path.
Tickeron AI Verdict
Based on observable factors including recent trend consistency from product launches and buyback authorization, Alcon Inc. (ALC) appears to hold a probabilistic edge in Tickeron’s AI assessment for current conditions. MDT’s larger scale and dividend profile provide defensive attributes, yet relative positioning shows more variability in momentum signals. The verdict reflects data-driven pattern recognition rather than certainty, with outcomes dependent on evolving market and company-specific developments.
Disclaimer
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ALC is a Buy and MDT is a Hold.
Long-Term Analysis
It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).
ALC’s FA Score shows that 1 FA rating(s) are green whileMDT’s FA Score has 1 green FA rating(s).
- ALC’s FA Score: 1 green, 4 red.
- MDT’s FA Score: 1 green, 4 red.
Short-Term Analysis
It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.
If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.
ALC’s TA Score shows that 4 TA indicator(s) are bullish while MDT’s TA Score has 5 bullish TA indicator(s).
- ALC’s TA Score: 4 bullish, 3 bearish.
- MDT’s TA Score: 5 bullish, 5 bearish.
Price Growth
ALC (@Pharmaceuticals: Other) experienced а -1.67% price change this week, while MDT (@Medical/Nursing Services) price change was -1.38% for the same time period.
The average weekly price growth across all stocks in the @Pharmaceuticals: Other industry was -1.77%. For the same industry, the average monthly price growth was -0.42%, and the average quarterly price growth was -14.37%.
The average weekly price growth across all stocks in the @Medical/Nursing Services industry was -0.01%. For the same industry, the average monthly price growth was -3.66%, and the average quarterly price growth was -16.13%.
Reported Earning Dates
ALC is expected to report earnings on Aug 10, 2026.
MDT is expected to report earnings on Aug 25, 2026.
Industries' Descriptions
@Pharmaceuticals: Other (-1.77% weekly)Pharmaceuticals (Other) comprise companies that are involved in the discovery, development or manufacturing of therapeutic and preventative medicines. They often collaborate with or acquire other pharmaceutical/healthcare firms. Examples of companies in this segment include Bausch Health Companies Inc., Icon Plc and Perrigo Company Plc.
@Medical/Nursing Services (-0.01% weekly)The medical/nursing services includes companies that provide medical-related services such as ambulance services, dialysis centers, respiratory therapy, blood testing and rehabilitation services. DaVita Inc., Chemed Corporation and Guardant Health, Inc. are examples of companies in this industry.
| ALC | MDT | ALC / MDT | |
| Capitalization | 31.9B | 101B | 32% |
| EBITDA | 2.54B | 9.36B | 27% |
| Gain YTD | -17.295 | -16.805 | 103% |
| P/E Ratio | 39.03 | 21.25 | 184% |
| Revenue | 10.6B | 35.5B | 30% |
| Total Cash | 1.66B | 8.38B | 20% |
| Total Debt | 5.25B | 28.1B | 19% |
ALC | MDT | ||
|---|---|---|---|
OUTLOOK RATING 1..100 | 9 | 12 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 18 Undervalued | 3 Undervalued | |
PROFIT vs RISK RATING 1..100 | 100 | 100 | |
SMR RATING 1..100 | 89 | 74 | |
PRICE GROWTH RATING 1..100 | 73 | 61 | |
P/E GROWTH RATING 1..100 | 49 | 62 | |
SEASONALITY SCORE 1..100 | 50 | 50 |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
MDT's Valuation (3) in the Medical Specialties industry is in the same range as ALC (18) in the Hospital Or Nursing Management industry. This means that MDT’s stock grew similarly to ALC’s over the last 12 months.
MDT's Profit vs Risk Rating (100) in the Medical Specialties industry is in the same range as ALC (100) in the Hospital Or Nursing Management industry. This means that MDT’s stock grew similarly to ALC’s over the last 12 months.
MDT's SMR Rating (74) in the Medical Specialties industry is in the same range as ALC (89) in the Hospital Or Nursing Management industry. This means that MDT’s stock grew similarly to ALC’s over the last 12 months.
MDT's Price Growth Rating (61) in the Medical Specialties industry is in the same range as ALC (73) in the Hospital Or Nursing Management industry. This means that MDT’s stock grew similarly to ALC’s over the last 12 months.
ALC's P/E Growth Rating (49) in the Hospital Or Nursing Management industry is in the same range as MDT (62) in the Medical Specialties industry. This means that ALC’s stock grew similarly to MDT’s over the last 12 months.
| ALC | MDT | |
|---|---|---|
| RSI ODDS (%) | 6 days ago 46% | 2 days ago 63% |
| Stochastic ODDS (%) | 2 days ago 59% | 2 days ago 52% |
| Momentum ODDS (%) | 2 days ago 51% | 2 days ago 56% |
| MACD ODDS (%) | 2 days ago 60% | 2 days ago 49% |
| TrendWeek ODDS (%) | 2 days ago 49% | 2 days ago 56% |
| TrendMonth ODDS (%) | 2 days ago 50% | 2 days ago 45% |
| Advances ODDS (%) | 2 days ago 58% | 8 days ago 51% |
| Declines ODDS (%) | 8 days ago 56% | 16 days ago 58% |
| BollingerBands ODDS (%) | N/A | 2 days ago 63% |
| Aroon ODDS (%) | 2 days ago 46% | 2 days ago 55% |
Advertisement
ALC and
Correlation & Price change
A.I.dvisor indicates that over the last year, ALC has been loosely correlated with SYK. These tickers have moved in lockstep 54% of the time. This A.I.-generated data suggests there is some statistical probability that if ALC jumps, then SYK could also see price increases.
MDT and
Correlation & Price change
A.I.dvisor indicates that over the last year, MDT has been loosely correlated with SYK. These tickers have moved in lockstep 53% of the time. This A.I.-generated data suggests there is some statistical probability that if MDT jumps, then SYK could also see price increases.